http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5740503-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd569fbfa1953ca9b7b375510e4d2763
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-287
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01D15-327
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0075
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D15-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-287
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-08
filingDate 1980-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_617e4797aa91d673efe0df6b1919970f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_389e8218f9b5d08085b13322cb4e8c7d
publicationDate 1982-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5740503-A
titleOfInvention Separation of saccharides
abstract PURPOSE: Saccharides are separated using hydrophobic chromatography to obtain plural fractions with different physiological activities, e.g., mucosaccharides used as medicines such as heparin, an anticoagulant, in high efficiency. n CONSTITUTION: Saccharides are separated and purified using hydrophobic chromatography to effect adsorption and elution. As saccharides, are used heparin, chondroitin sulfuric acid, dermatan sulfate, hyaluronic acid or chondroitin-polysulfuric acid. A buffer solution of saccharides is passed through a column filled with a chromatography carrier bearing hydrophobic ligands such as alkyl, substituted alkyl, aryl or aralkyl groups such as octylagarose to effect adsorption. Then, an eluting solution is passed through to effect fractionation, thus obtaining the objective isolated and purified saccharide. n COPYRIGHT: (C)1982,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010053259-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10436469-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10495104-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10563667-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10406470-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10518205-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S58183701-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0316169-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009173945-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10413857-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10508658-B2
priorityDate 1980-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414784756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32756

Total number of triples: 38.